| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 286,852 | 284,567 | 242,972 | 248,076 | | Cost of Revenue | 147,436 | 141,633 | 125,371 | 133,050 | | | Gross Profit | 139,416 | 142,934 | 117,601 | 115,026 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 93,233 | 91,806 | 81,988 | 84,120 | | Non Recurring | 30 | (18) | (5) | 23 | | Others | 9,321 | 9,374 | 9,429 | 9,096 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 36,832 | 41,772 | 26,189 | 21,787 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (152) | | Earnings Before Interest And Taxes | 36,832 | 41,772 | 26,189 | 21,635 | | Interest Expense | 159 | 259 | 428 | 761 | | Income Before Tax | 36,673 | 41,513 | 25,761 | 20,874 | | Income Tax Expense | 13,940 | 16,031 | 9,953 | 8,321 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,733 | 25,482 | 15,808 | 12,553 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,733 | 25,482 | 15,808 | 12,553 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $22,733 | $25,482 | $15,808 | $12,553 |
|
0.51% Nasdaq 
Income Statement
